Occult Hepatitis B Virus Infection in Immunized Infants Born to Untreated and Tenofovir-Treated Highly Viremic Mothers

Tenofovir disoproxil fumurate (TDF) therapy during late pregnancy in highly viremic mothers can reduce residual overt hepatitis B virus (HBV) infections of their infants that occur despite immunoprophylaxis.1,2 Occult HBV infection (OBI) has been defined as the presence of HBV DNA in liver or sera i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical gastroenterology and hepatology 2021-07, Vol.19 (7), p.1494-1496
Hauptverfasser:	Hsu, Hong-Yuan, Chen, Huey-Ling, Wu, Jia-Feng, Ni, Yen-Hsuan, Chang, Kai-Chi, Chiang, Cheng-Lun, Lee, Chien-Nan, Zhao, Lu-Lu, Lai, Ming-Wei, Mu, Shu-Chi, Wen, Wan-Hsin, Lin, Lung-Huang, Chang, Mei-Hwei, MK, Shyu, HL, Hwa, YN, Su, JC, Shih, KH, Chao, YC, Chiu, CJ, Liu, TH, Su, DS, Chen, SM, Chen, CC, Lin, PY, Lin, WR, Yang, JJ, Hu, CK, Yang, YK, Chang, KH, Chen, HH, Lin, YH, Lin, HJ, Chen, HS, Pan, BH, Lau, CL, Lee, PJ, Cheng, YL, Chang, HY, Chiueh, TH, Wang, JJ, Hsu, LM, Lo, CL, Hsieh, SW, Cheng, MS, Tsai, BQ, She, FS, Peng, YC, Lin, CP, Chen, JP, Huang, CY, Yeung
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Tenofovir disoproxil fumurate (TDF) therapy during late pregnancy in highly viremic mothers can reduce residual overt hepatitis B virus (HBV) infections of their infants that occur despite immunoprophylaxis.1,2 Occult HBV infection (OBI) has been defined as the presence of HBV DNA in liver or sera in subjects seronegative for hepatitis B surface antigen (HBsAg).3 OBI has been found in varying proportions of immunized infants born to HBsAg-positive mothers.4-6 We aimed to investigate the impact of maternal TDF therapy during pregnancy on vertically acquired OBI.
ISSN:	1542-3565 1542-7714
DOI:	10.1016/j.cgh.2020.07.041